| Lane | Service | Code | Billing Consideration |
|---|---|---|---|
| CLINIC | Comprehensive Exam, New | 92004 | Anchor new-patient exam. Payer edits against same-day procedures. |
| OCT, Retina | 92134 | Anchors medical retina claims including injection follow-up. | |
| Intravitreal Injection | 67028 | Reports injection only. Drug reports separately with J-code. | |
| SURGICAL | Cataract Surgery + IOL | 66984 | 10-day global period. Bilateral and staging conventions apply. |
| YAG Capsulotomy | 66821 | Frequency and medical-necessity edits. Timing draws review. | |
| Laser Trabeculoplasty | 65855 | Repeat-treatment windows and session counts are edit points. |
Every ophthalmology practice runs two revenue engines at once, a high-volume clinic lane and a procedure lane, and each fails differently. ProvidaRCM bills ophthalmology practices across both, from 92004 exams to cataract surgery, with the global-period and bundling discipline the specialty demands. We handle eligibility verification, prior authorization, coding, claims, and denial recovery.
The clinic lane generates volume, the surgical lane generates value, and the claims that fail most often are the ones where the two lanes touch.
Comprehensive and intermediate exams, ophthalmic diagnostics, and office injections. High visit frequency, dense payer edits, and a drug component that moves independently of the professional fee.
Cataract and anterior segment procedures, glaucoma lasers, and retina lasers. Payment concentrates into fewer, larger claims where global periods, bilateral staging, and device documentation decide the yield.
A clinic table and a surgical table, because ophthalmology billing is really two code bases with one set of bundling rules across them.
| Code | Description | Billing Consideration |
|---|---|---|
| 92002 | Intermediate ophthalmological exam, new patient | Selected over 92004 when the visit does not meet comprehensive criteria as documented. |
| 92004 | Comprehensive ophthalmological exam, new patient | The anchor new-patient exam. Payers edit 92004 against same-day procedures for bundling. |
| 92012 | Intermediate ophthalmological exam, established patient | Common recheck code. Frequency and bundling edits vary by plan. |
| 92014 | Comprehensive ophthalmological exam, established patient | High-volume code. Must not be selected by habit when the visit was intermediate. |
| 92015 | Determination of refractive state | Often a patient-responsibility service; many payers bundle or exclude it. |
| 92083 | Extended visual field examination | Requires the documented indication, typically glaucoma monitoring. |
| 92133 | Optical coherence tomography, optic nerve | Glaucoma follow-up frequency edits apply; pair with the correct glaucoma diagnosis stage. |
| 92134 | Optical coherence tomography, retina | Anchors medical retina claims including injection follow-up. |
| 76512 | Ophthalmic ultrasound, B-scan | Bundled into some surgical encounters; separately billable where media opacity prevents view. |
| Code | Description | Billing Consideration |
|---|---|---|
| 66984 | Cataract surgery with IOL insertion | 10-day global period under Medicare. Second-eye staging and bilateral conventions drive the most frequent errors. |
| 66982 | Complex cataract surgery | Reports documented complexity such as small pupil or zonular weakness, not surgical inconvenience. |
| 66821 | YAG laser posterior capsulotomy | Frequency and medical-necessity edits apply; timing after cataract surgery draws payer review. |
| 65855 | Laser trabeculoplasty | Number of sessions and repeat-treatment windows are common edit points. |
| 67028 | Intravitreal injection | Reports the injection service only; the drug reports separately with its own J-code and acquisition documentation. |
| 67228 | Panretinal photocoagulation | Multi-session treatment sequences require staging documentation to pay correctly. |
| 67101 | Pars plana vitrectomy (verify) | Verify the current CPT description and the payer's bundling edits before submission. |
| 66725 | Insertion of anterior chamber intraocular lens (verify) | Verify the current CPT description and the payer's coverage before billing. |
Coverage, bundling, and global periods vary by payer, plan, and calendar year, and every code must be supported by the examination or procedure documentation. We verify current payer policy before submission.
Cataract surgery 66984 carries a 10-day global period under Medicare, and what is separately billable changes at every step of the way.
Biometry, B-scan where media are opaque, and the surgical consent visit. Billable before the global period begins.
66984 reports the procedure. Bilateral conventions and first-eye versus second-eye sequencing must match the documentation.
The Medicare global period. Routine post-operative care is included, not separately billable.
Post-operative exams and related services return to normal billing rules, and YAG capsulotomy follows its own documentation path.
From a comprehensive exam to a complex cataract case, every ophthalmology line carries its own bundling, global-period, and bilateral rules. We bill the full range a practice delivers.
The surgical lane's revenue engine. Cataract surgery with IOL insertion, complex cataract with documented complexity, and anterior segment repair, each with a 10-day Medicare global period, bilateral staging conventions, and first-eye versus second-eye sequencing that must match the documentation. We run a per-patient global calendar so nothing inside the window bills separately by habit.
Intravitreal injections and OCT follow-up, with the drug J-code, units, and waste documentation reconciled to the injection record on every claim.
Laser trabeculoplasty, visual fields, and OCT nerve imaging, with stage-specific diagnosis coding and repeat-treatment windows tracked.
Office visits coded from the documented exam scope, not by habit, with frequency and bundling edits applied per payer.
Refraction 92015 is frequently a patient-responsibility service, and we apply the payer's stated policy at claim build with patient communication moved upstream.
OCT, visual fields, and B-scan, with the documented indication and the payer's same-day bundling rules applied at claim build.
Retina and optic nerve OCT, with frequency edits and diagnosis pairing verified before submission so the diagnostic claim pays.
Intravitreal drug J-codes, units, and waste documentation reconciled against the injection record and the buy-and-bill log.
Modifier 50 or the RT and LT pair applied per payer convention, with second-eye staging verified against the surgical calendar.
Four recurring failure modes, each with a fix we build into the workflow.
Same-day bilateral cataract surgery, staged second eyes, and payer-specific bilateral conventions produce a steady stream of denials and underpayments.
Fix: Eye-level documentation capture, payer-specific bilateral convention applied, and second-eye staging verified against the surgical calendar.
Diagnostics ordered the day of surgery, or exams billed the day of the procedure, get bundled into the surgical payment and the practice never notices.
Fix: Encounter-level bundling screening, with separately documented decision making the only path to reporting both.
The 67028 injection reports correctly while the drug's J-code, unit count, and acquisition documentation do not line up, and the drug payment denies or underpays.
Fix: Drug, dose, and J-code reconciled against the injection record and the buy-and-bill documentation on every injection claim.
Refraction billed where payers bundle it, refractive procedures billed with covered cataract services, and patients surprised by all of it.
Fix: Payer-specific refraction policy applied at claim build, with patient financial communication moved to the pre-surgery visit.
The clinic lane punishes slow claim turns, the surgical lane punishes bundling errors, and an in-house desk has to fight both at once.
| Measure | Typical In-House Desk | With ProvidaRCM |
|---|---|---|
| First-pass acceptance | 95% industry average | 99% clean claim rate |
| Days in A/R | 35 to 45 days is common | 24 days |
| Denial rate | Bundling and global-period denials recur monthly | 2.1% denial rate with root-cause fixes |
| Global-period management | Tracked manually, if at all | Per-patient global calendar at charge entry |
| Injection drug capture | J-code variance discovered at payment | Drug, dose, and J-code reconciled per claim |
| Bilateral staging | Convention applied inconsistently | Payer-specific convention per claim |
| Revenue impact | Static at best | 20 to 25% within 90 days |
If any of these are true, your current billing is quietly costing you across clinic volume and surgical value. A free audit will show exactly how much.
Clinical-to-billing crossover questions we answer every week. Coverage and global periods vary by payer, plan, and year.
Sometimes. A significant, separately identifiable evaluation and management service, attested with modifier 25, can be reported alongside the injection when the documentation supports a distinct visit beyond the pre-injection evaluation the injection service already includes. Payers scrutinize this pairing on medical retina claims heavily, so the examination note must stand on its own before both lines report.
Cataract surgery 66984 carries a 10-day global period under Medicare, during which routine post-operative care is included rather than separately billable. Return visits related to complications can be reportable with the appropriate modifiers where documentation supports them, and payer policies vary. We run a per-patient global calendar so nothing inside the window bills separately by habit.
Refraction 92015 is one of the most misunderstood lines in eye care. Many payers bundle it or exclude it, some plans cover it only with a medical indication, and Medicare generally treats it as non-covered, which makes it a patient-responsibility service where notice matters. We apply the payer's stated policy at claim build and make sure patient communication happens before the refraction is performed, not after the denial.
The injection service 67028 reports the professional act, and the drug reports separately under its own J-code with the dose and waste documentation attached. The two most common failures are quantity errors that understate the drug units and missing acquisition-cost documentation that weakens appeals on underpayment. We reconcile drug, dose, units, and documentation on every injection claim.
It depends on whether the payer's convention calls for modifier 50, the RT and LT pair, or a stated bilateral rule for the eye codes, and on whether the payer prices same-day bilateral surgery or requires staging. Second-eye surgery on a later date reports under its own encounter with its own global period. We apply each payer's stated convention and verify staging against the surgical calendar.
66982 reports cataract surgery complicated by factors that increase complexity, such as a small pupil requiring expansion devices or zonular weakness, and the operative note must document those circumstances. Selecting the complex code without the documented complexity is one of the highest-audit claims in ophthalmology, so we code strictly from the surgical report and return unsupported selections to the surgeon with the reason.
Diagnostics performed on the same date as surgery, such as B-scan 76512 before cataract surgery in an eye with media opacity, are reportable only where the documentation and payer policy support them, and many payers bundle same-day diagnostics into the procedure. We apply each payer's bundling rules at claim build, so payable pre-operative diagnostics are captured and bundling exposure is not created.
Cataract claims rest on age-related cataract codes such as H25.9 with laterality, glaucoma claims on the stage-specific H40.11x series, and medical retina claims on the E11.31x diabetic retinopathy codes paired with the retinopathy H35.3x codes. Stage and laterality characters must come from the documentation. Diagnosis specificity is what separates a paid diagnostic claim from a bundled one.
Pricing starts at 2.49% of monthly collections, with no setup fees, no long-term contracts, and month-to-month terms. The arrangement continues only as long as the numbers justify it, which is why our retention stays high. See the full service scope on our medical billing service page.
ProvidaRCM bills ophthalmology across clinic and surgical lanes with 99% clean claims, a 2.1% denial rate, and 24 days in A/R. 500+ providers nationwide trust the cycle we run, and every engagement starts with a look at your actual numbers, not a pitch.
